Joining forces would help the smaller Japanese automakers add scale to compete with Japan’s market leader Toyota Motor Corp.

Teva Pharmaceutical Industries Ltd. ADR 26.47% $18.82B ...

But, increased costs became a drag on net income in 2023 as firms invested in technology and infrastructure. Further ...

incorporated in the year 1924, is a Large Cap company (having a market cap of Rs 38,541.57 Crore) operating in Pharmaceuticals sector. GlaxoSmithKline Pharmaceuticals Ltd. key Products/Revenue ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

The potential for TL1A-targeting duvakitug to impact unmet needs of patients with ulcerative colitis (UC) and Crohn’s disease (CD), and to provide anti-fibrotic effects for a host of other diseases, ...